Resultados de la búsqueda 441-450 of 5014 for 搜索留痕软件咨询邮箱：lgooxc@hotmail.com

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  2. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Obtén información acerca de este cáncer frecuente, incluso sobre la prevención, los síntomas, el diagnóstico y el tratamiento.

  3. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

  4. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  5. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous prostate tissue. This ...

  8. Nuestros estudiantes - Mayo Clinic

    Los programas que encaminan a los estudiantes y son parte de la Oficina para Diversidad Educativa, Equidad e Inclusión en Mayo Clinic abarcan el trayecto ...

  9. Oncología (médica) - Ensayos clínicos

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  10. Oncología (médica) - Ensayos clínicos

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...